|
|
Blood, 15 October 2004, Vol. 104, No. 8, pp. 2315-2322.
Prepublished online as a Blood First Edition Paper on July 1, 2004; DOI 10.1182/blood-2004-01-0204.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo
Suzanne M. Vercauteren, and
Heather J. Sutherland
From the Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada; and the Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Notch transmembrane receptors are known to play a critical role in cell-fate decisions, with Notch1 shown to enhance self-renewal of hematopoietic stem cells and cause T-cell leukemia. Four Notch receptors exist, and the extent of redundancy and overlap in their function is unknown. Notch4 is structurally distinct from Notch1 through Notch3 and has not been extensively studied in hematopoiesis. By polymerase chain reaction (PCR) we find Notch4 transcript expression in human marrow cells and in both CD34+ and CD34– populations. When constitutively active Notch1 or Notch4 was overexpressed in normal human marrow or cord cells, we found reduced colony-forming and short-term proliferative ability while the primitive progenitor content of myeloid long-term cultures was significantly increased. Notch4–intracellular domain (Notch4-IC)–transduced cord cells transplanted into  2-microglobulin–/– nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in significantly higher levels of engraftment of both green fluorescent protein–positive (GFP+) and GFP– populations as compared with controls. GFP+ cells in bone marrow and spleen of animals that had received transplants gave rise to an immature CD4+CD8+ T-cell population, whereas B-cell development was blocked. These results indicate that activation of Notch4 results in enhanced stem cell activity, reduced differentiation, and altered lymphoid development, suggesting it may influence both stem cells and the fate of the common lymphoid progenitor.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Stem cell expansion: success and complexities
- Stefan Karlsson
Blood 2004 104: 2210-2211.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
X.-B. Zhang, J. L. Schwartz, R. K. Humphries, and H.-P. Kiem
Effects of HOXB4 Overexpression on Ex Vivo Expansion and Immortalization of Hematopoietic Cells from Different Species
Stem Cells,
August 1, 2007;
25(8):
2074 - 2081.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Chadwick, M. C. Nostro, M. Baron, R. Mottram, G. Brady, and A.-M. Buckle
Notch Signaling Induces Apoptosis in Primary Human CD34+ Hematopoietic Progenitor Cells
Stem Cells,
January 1, 2007;
25(1):
203 - 210.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen, A. Crabbe, V. Van Duppen, and H. Vankelecom
The Notch Signaling System Is Present in the Postnatal Pituitary: Marked Expression and Regulatory Activity in the Newly Discovered Side Population
Mol. Endocrinol.,
December 1, 2006;
20(12):
3293 - 3307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Yu, D. X. Chen, Q. X. Zhou, N. Fang, and Z. L. Liu
Effects of Histamine on Immunophenotype and Notch Signaling in Human HL-60 Leukemia Cells.
Experimental Biology and Medicine,
November 1, 2006;
231(10):
1633 - 1637.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Yu, J. K. Alder, J. H. Chun, A. D. Friedman, S. Heimfeld, L. Cheng, and C. I. Civin
HES1 Inhibits Cycling of Hematopoietic Progenitor Cells via DNA Binding
Stem Cells,
April 1, 2006;
24(4):
876 - 888.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Delaney, B. Varnum-Finney, K. Aoyama, C. Brashem-Stein, and I. D. Bernstein
Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells
Blood,
October 15, 2005;
106(8):
2693 - 2699.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Subramanian, Y.-S. Yim, K. Liu, K. Tus, X. J. Zhou, and E. K. Wakeland
Epistatic Suppression of Systemic Lupus Erythematosus: Fine Mapping of Sles1 to Less Than 1 Mb
J. Immunol.,
July 15, 2005;
175(2):
1062 - 1072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
